" /> Ponesimod - CISMeF





Preferred Label : Ponesimod;

NCIt synonyms : (2Z,5Z)-5-(3-chloro-4-((2R)-2,3-dihydroxypropoxy)phenylmethylidene)-3-(2-methylphenyl)-2-(propylimino)-1,3-thiazolidin-4-one;

NCIt definition : An orally available sphingosine-1-phosphate receptor 1 (S1PR1, S1P1) agonist that acts as a functional antagonist, with potential immunomodulating activity. Upon oral administration, ponesimod selectively binds to S1PR1 on lymphocytes and causes transient receptor activation followed by S1PR1 internalization and degradation. This results in the sequestration of lymphocytes in lymph nodes. By preventing egress of lymphocytes, ponesimod reduces both the amount of circulating peripheral lymphocytes and the infiltration of lymphocytes into target tissues. This prevents a lymphocyte-mediated immune response. S1PR1, a G-protein coupled receptor, plays a key role in lymphocyte migration from lymphoid tissues.;

UNII : 5G7AKV2MKP;

InChIKey : LPAUOXUZGSBGDU-STDDISTJSA-N;

CAS number : 854107-55-4;

Molecule name : ACT 128800; ACT-128800;

Chemical formula : C23H25ClN2O4S;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
18/06/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.